How big is the Global Sex Reassignment Surgery Market?

The Global Sex Reassignment Surgery Market size is expected to reach USD 1.26 billion in 2024 and grow at a CAGR of 12.20% to reach USD 2.24 billion by 2029. Read More

What is the current Global Sex Reassignment Surgery Market size?

In 2024, the Global Sex Reassignment Surgery Market size is expected to reach USD 1.26 billion. Read More

Who are the key players in Global Sex Reassignment Surgery Market?

Mount Sinai, Boston Medical Center, CNY Cosmetics & Reconstructive Surgery, Phuket Plastic Surgery Institute and IM Gender Clinic are the major companies operating in the Global Sex Reassignment Surgery Market. Read More

Which is the fastest growing region in Global Sex Reassignment Surgery Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Global Sex Reassignment Surgery Market?

In 2024, the North America accounts for the largest market share in Global Sex Reassignment Surgery Market. Read More

What years does this Global Sex Reassignment Surgery Market cover, and what was the market size in 2023?

In 2023, the Global Sex Reassignment Surgery Market size was estimated at USD 1.11 billion. The report covers the Global Sex Reassignment Surgery Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Sex Reassignment Surgery Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

What are the factors driving the Sex Reassignment Surgery Market?

The factors driving the Sex Reassignment Surgery Market are a) Increased awareness and acceptance of transgender identities b) Growing demand for facial surgeries and non-genital surgeries Read More

Global Sex Reassignment Surgery Companies

This report lists the top Global Sex Reassignment Surgery companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Global Sex Reassignment Surgery industry.